Business

Director’s Dealing

Director’s Dealing.

articleSareum Holdings PlcMarch 27, 20253/company/sareum-hldgs-plc/news/directors-dealing-23
Director’s Dealing

About this update from Sareum Holdings Plc

[{"type":"text","content":"\n\nSareum Holdings PLC\n(\"Sareum\" or the \"Company\")\nDirector's Dealing\nCambridge, UK, 27 March 2025 - Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, announces that Dr Stephen Parker, Executive Chairman, purchased 84,033 ordinary shares of 1.25 pence each in the capital of the Company (\"Ordinary Shares\") at an average price of 11.9 pence per share on 26 March 2025.  \nIn addition, persons connected with Dr Parker are interested in a further 25,680 Ordinary Shares in the Company, over which Ordinary Shares Dr Parker has voting rights discretion.\nTherefore, following the transaction, Dr Parker has direct and indirect interests in an aggregate 405,045 Ordinary Shares in the Company, representing approximately 0.30 per cent. of the Company's currently issued share capital.\nThe notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provides further details.\nPDMR Notification Form:\n\n\n\n\n1\n\n\nDetails of the person discharging managerial responsibilities/person closely associated\n \n\n\n\n\na)   \n\n\nName\n\n\nStephen Parker\n\n\n\n\n2\n\n\nReason for the notification\n\n\n\n\na)   \n\n\nPosition/status\n\n\nExecutive Chairman\n\n\n\n\nb)   \n\n\nInitial notification/amendment\n\n\nInitial notification\n\n\n\n\n3\n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n\n\n\n\na)   \n\n\nName\n\n\nSareum Holdings plc\n\n\n\n\nb)   \n\n\nLEI\n\n\n213800PKERN2DY8FFM72\n\n\n\n\n4\n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na)   \n\n\nDescription of the financial instrument, type of instrument\n\n\nOrdinary shares of 1.25 pence each in the share capital of Sareum Holdings plc\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nIdentification code\n\n\nGB00B02RFS12\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nb)   \n\n\nNature of the transaction\n\n\nPurchase of shares\n\n\n\n\nc)   \n\n\nPrice(s) and volume(s)\n\n\n\n\n\...

More updates from Sareum Holdings Plc